Information Provided By:
Fly News Breaks for September 25, 2015
Sep 25, 2015 | 09:11 EDT
Piper Jaffray analyst William Quirk lowered his price target for Sequenom to $2.40 after the company guided second half of 2015 revenue below expectations. Quirk remains cautious on Sequenom saying the patent pool transition is impacting the top-line. He keeps a Neutral rating on the stock.
News For SQNM From the Last 2 Days
There are no results for your query SQNM